Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE.

Blanco Sánchez, Alberto; Gil Manso, Rodrigo; Carreño-Tarragona, Gonzalo; Paredes Ruiz, Diana; González Olmedo, Jesús; Martínez-López, Joaquín; Díaz Pedroche, Carmen; Ayala, Rosa

Blanco Sánchez, Alberto; Gil Manso, Rodrigo; Carreño-Tarragona, Gonzalo; Paredes Ruiz, Diana; González Olmedo, Jesús; Martínez-López, Joaquín; Díaz Pedroche, Carmen; Ayala, Rosa.

Afiliação

Blanco Sánchez A; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Gil Manso R; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Carreño-Tarragona G; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Paredes Ruiz D; Department of Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.
González Olmedo J; Department of Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.
Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Díaz Pedroche C; Department of Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ayala R; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Front Pharmacol ; 14: 1206893, 2023.

Article em En | MEDLINE | ID: mdl-37538175

Palavras-chave

SCORE; cardiovascular risk; chronic myeloid leukemia (CML); coronary disease; multidisciplinary management; thromboembolic disease; tyrosine kinase inhibitor (TKI)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article